Wedbush Maintains Neutral on Cerence, Raises Price Target to $32

Wedbush analyst Daniel Ives maintains Cerence (NASDAQ:CRNC) with a Neutral and raises the price target from $25 to $32.

Wedbush analyst Daniel Ives maintains Cerence (NASDAQ:CRNC) with a Neutral and raises the price target from $25 to $32.

Total
0
Shares
Related Posts
Read More

FINMA Approves Merger Of UBS And Credit Suisse

The Swiss Financial Market Supervisory Authority FINMA has approved the takeover of Credit Suisse by UBS. FINMA welcomes the takeover solution and the measures taken by the Swiss Confederation and the Swiss National Bank SNB. The transaction and the measures taken will ensure stability for the bank's customers and for the financial centre.

CS